Literature DB >> 11770108

Use of genetic complementation to identify gene(s) which specify species-specific organ tropism of Leishmania.

C Hoyer1, K Mellenthin, M Schilhabel, M Platzer, J Clos.   

Abstract

We have employed a genetic complementation screening to identify genetic markers of heat stress tolerance and visceralisation of Leishmania infection. Leishmania major, which has a low thermotolerance and which causes cutaneous lesions, was transfected with a cosmid library of L. donovani DNA. The recombinant parasites were then screened either for thermotolerance or selected by repeated passage in BALB/c mice. Cosmids which conferred selective advantage were isolated. Several strategies were tested to identify the gene(s) within the cosmids responsible for the observed selective advantages. Of the approaches tested, the complete sequence analysis of the cosmids and subsequent screening of defined candidate ORFs proved to be the method of choice. Other approaches, such as creation of sub-libraries or transposon insertion strategies proved to be unsuccessful.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770108     DOI: 10.1007/s004300100077

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  4 in total

1.  Stage-specific expression of the mitochondrial co-chaperonin of Leishmania donovani, CPN10.

Authors:  Fanny Beatriz Zamora-Veyl; Manfred Kroemer; Dorothea Zander; Joachim Clos
Journal:  Kinetoplastid Biol Dis       Date:  2005-04-29

Review 2.  Determinants for the development of visceral leishmaniasis disease.

Authors:  Laura-Isobel McCall; Wen-Wei Zhang; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

3.  A novel marker, ARM58, confers antimony resistance to Leishmania spp.

Authors:  Andrea Nühs; Carola Schäfer; Dorothea Zander; Leona Trübe; Paloma Tejera Nevado; Sonja Schmidt; Jorge Arevalo; Vanessa Adaui; Louis Maes; Jean-Claude Dujardin; Joachim Clos
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-06       Impact factor: 4.077

4.  Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.

Authors:  Victoriano Corpas-Lopez; Sonia Moniz; Michael Thomas; Richard J Wall; Leah S Torrie; Dorothea Zander-Dinse; Michele Tinti; Stephen Brand; Laste Stojanovski; Sujatha Manthri; Irene Hallyburton; Fabio Zuccotto; Paul G Wyatt; Manu De Rycker; David Horn; Michael A J Ferguson; Joachim Clos; Kevin D Read; Alan H Fairlamb; Ian H Gilbert; Susan Wyllie
Journal:  ACS Infect Dis       Date:  2018-11-12       Impact factor: 5.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.